Open-label Evaluation of the Pharmacokinetic Profile, Safety, and Efficacy of Tapentadol Oral Solution for the Treatment of Post-surgical Pain in Children and Adolescents Aged From 2 Years to Less Than 18 Years
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 04 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2013 Planned end date changed from 1 Nov 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 05 Oct 2013 Planned number of patients changed from 52 to 56 as reported by ClinicalTrials.gov.